vs
Side-by-side financial comparison of Globe Life (GL) and SCOTTS MIRACLE-GRO CO (SMG). Click either name above to swap in a different company.
Globe Life is the larger business by last-quarter revenue ($1.6B vs $1.5B, roughly 1.1× SCOTTS MIRACLE-GRO CO). Globe Life runs the higher net margin — 17.3% vs 16.3%, a 1.0% gap on every dollar of revenue. On growth, Globe Life posted the faster year-over-year revenue change (5.3% vs -16.9%). Over the past eight quarters, SCOTTS MIRACLE-GRO CO's revenue compounded faster (10.2% CAGR vs 4.1%).
Globe Life Inc. (GL) is an American financial services holding company listed on the New York Stock Exchange which operates through its wholly owned subsidiaries providing life insurance, annuity, and supplemental health insurance products. The company is based in McKinney, Texas.
The Scotts Miracle-Gro Company is an American multinational corporation headquartered in Marysville, Ohio, where O.M. Scott began selling lawn seed in 1868. The company manufactures and sells consumer lawn, garden and pest control products, as well as soilless indoor gardening equipment. In the U.S., the company manufactures Scotts, Miracle-Gro and Ortho brands. It also markets and distributes the herbicide Roundup in the U.S. and several international markets including China.
GL vs SMG — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.6B | $1.5B |
| Net Profit | $270.5M | $238.6M |
| Gross Margin | — | 41.8% |
| Operating Margin | — | 27.5% |
| Net Margin | 17.3% | 16.3% |
| Revenue YoY | 5.3% | -16.9% |
| Net Profit YoY | — | 61.2% |
| EPS (diluted) | $3.39 | $-2.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.6B | $1.5B | ||
| Q4 25 | $1.5B | $354.4M | ||
| Q3 25 | $1.5B | $387.3M | ||
| Q2 25 | $1.5B | $1.2B | ||
| Q1 25 | $1.5B | $1.4B | ||
| Q4 24 | $1.5B | $416.8M | ||
| Q3 24 | $1.5B | $414.7M | ||
| Q2 24 | $1.4B | $1.2B |
| Q1 26 | $270.5M | $238.6M | ||
| Q4 25 | $266.1M | $-125.0M | ||
| Q3 25 | $387.8M | — | ||
| Q2 25 | $252.7M | $149.1M | ||
| Q1 25 | $254.6M | $217.5M | ||
| Q4 24 | $255.2M | $-69.5M | ||
| Q3 24 | $303.0M | — | ||
| Q2 24 | $258.4M | $132.1M |
| Q1 26 | — | 41.8% | ||
| Q4 25 | — | 25.0% | ||
| Q3 25 | — | 6.1% | ||
| Q2 25 | — | 31.8% | ||
| Q1 25 | — | 38.6% | ||
| Q4 24 | — | 22.7% | ||
| Q3 24 | 26.1% | -7.1% | ||
| Q2 24 | 23.3% | 29.5% |
| Q1 26 | — | 27.5% | ||
| Q4 25 | 21.7% | -6.2% | ||
| Q3 25 | 31.5% | -38.8% | ||
| Q2 25 | 21.2% | 18.1% | ||
| Q1 25 | 21.4% | 24.3% | ||
| Q4 24 | 21.3% | -12.2% | ||
| Q3 24 | 26.3% | -52.1% | ||
| Q2 24 | 23.5% | 16.6% |
| Q1 26 | 17.3% | 16.3% | ||
| Q4 25 | 17.5% | -35.3% | ||
| Q3 25 | 25.6% | — | ||
| Q2 25 | 17.1% | 12.6% | ||
| Q1 25 | 17.2% | 15.3% | ||
| Q4 24 | 17.4% | -16.7% | ||
| Q3 24 | 20.8% | — | ||
| Q2 24 | 17.9% | 11.0% |
| Q1 26 | $3.39 | $-2.00 | ||
| Q4 25 | $3.28 | $-2.16 | ||
| Q3 25 | $4.73 | $-2.58 | ||
| Q2 25 | $3.05 | $2.54 | ||
| Q1 25 | $3.01 | $3.72 | ||
| Q4 24 | $3.00 | $-1.21 | ||
| Q3 24 | $3.44 | $-4.21 | ||
| Q2 24 | $2.83 | $2.28 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $183.8M | $6.2M |
| Total DebtLower is stronger | — | $2.3B |
| Stockholders' EquityBook value | $6.1B | — |
| Total Assets | — | $3.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $183.8M | $6.2M | ||
| Q4 25 | $314.7M | $8.3M | ||
| Q3 25 | $62.8M | $36.6M | ||
| Q2 25 | $116.7M | $51.1M | ||
| Q1 25 | $134.1M | $16.9M | ||
| Q4 24 | $85.0M | $9.8M | ||
| Q3 24 | $100.5M | $71.6M | ||
| Q2 24 | $100.6M | $279.9M |
| Q1 26 | — | $2.3B | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | — |
| Q1 26 | $6.1B | — | ||
| Q4 25 | $6.0B | $-500.6M | ||
| Q3 25 | $5.7B | $-357.5M | ||
| Q2 25 | $5.4B | $-170.9M | ||
| Q1 25 | $5.4B | $-290.1M | ||
| Q4 24 | $5.3B | $-479.5M | ||
| Q3 24 | $4.6B | $-390.6M | ||
| Q2 24 | $5.2B | $-146.2M |
| Q1 26 | — | $3.4B | ||
| Q4 25 | $30.8B | $3.0B | ||
| Q3 25 | $30.5B | $2.7B | ||
| Q2 25 | $29.8B | $3.1B | ||
| Q1 25 | $29.7B | $3.5B | ||
| Q4 24 | $29.1B | $3.2B | ||
| Q3 24 | $29.6B | $2.9B | ||
| Q2 24 | $28.3B | $3.5B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GL
| Life premium | $853.2M | 55% |
| Health premium | $416.9M | 27% |
| Other | $289.5M | 19% |
SMG
Segment breakdown not available.
